A new agreement for Germany's IDT Biologika to help in the production of Johnson & Johnson's coronavirus vaccines would offer Europe greater certainty on the delivery of the jabs, Germany's economy minister said Monday. The deal, announced by IDT Biologika and Johnson & Johnson's German subsidiary Janssen, will allow the latter's newly approved single-dose vaccine to be filled and bottled on German soil amid fears over restrictions imposed by the United States on the export of domestically produced vaccines. "Vaccine production in Europe and Germany increases delivery certainty and is a very important signal in the current phase of the pandemic," said Economy Minister Peter Altmaier in a statement welcoming the agreement. kih/hmn/kjl